Showing 401 - 420 results of 26,678 for search '(( 50 ((nn decrease) OR (we decrease)) ) OR ( 100 ((nm decrease) OR (a decrease)) ))', query time: 0.89s Refine Results
  1. 401
  2. 402
  3. 403
  4. 404
  5. 405
  6. 406
  7. 407
  8. 408
  9. 409
  10. 410

    Analysis of the <sup>1</sup>H-<sup>15</sup>N HSQC Spectra of mS100A4 in Complex with EGF. by Ching Chang Cho (3080076)

    Published 2016
    “…<p>(A) Overlaid <sup>1</sup>H-<sup>15</sup>N HSQC spectra of 0.5 mM <sup>15</sup>N-labeled free mS100A4 (red) and mS100A4: EGF, molar ratio = 1:0.3 (green), 1:0.6 (blue), and 1:1 (white), with the intensity drop indicated by green boxes. …”
  11. 411

    Analysis of the <sup>1</sup>H-<sup>15</sup>N HSQC Spectra of mS100A4 in Complex with Amlexanox. by Ching Chang Cho (3080076)

    Published 2016
    “…(C) Ribbon representation of mS100A4, with residues that exhibited a decrease in cross-peak intensity mapped (red) on the ribbon diagram.…”
  12. 412
  13. 413
  14. 414
  15. 415

    Serum and urinary Klotho, S100A8/A9, and neutrophil gelatinase-associated lipocalin (NGAL) concentrations in acute kidney injury patients. by Ae Jin Kim (610338)

    Published 2016
    “…(b) Urinary S100A8/A9/Cr was increased significantly in intrinsic AKI patients. …”
  16. 416

    Serum and urinary Klotho, S100A8/A9, and Neutrophil gelatinase-associated lipocalin (NGAL) concentrations in an acute kidney injury model. by Ae Jin Kim (610338)

    Published 2016
    “…(b) Serum and urinary S100A8/A9 and urinary S100A8/A9/Cr increased significantly in the cisplatin (CDDP) group. …”
  17. 417

    Semiquantitative immunoblotting and immunohistochemistry of the kidney from the acute kidney injury model. by Ae Jin Kim (610338)

    Published 2016
    “…(b) S100A8/A9 abundance was increased in the CDDP group (220%) versus the control (100%) and VD groups (83%). …”
  18. 418

    Long-Term Effects of Botulinum Toxin Complex Type A Injection on Mechano- and Metabo-Sensitive Afferent Fibers Originating from <i>Gastrocnemius</i> Muscle by Guillaume Caron (816032)

    Published 2015
    “…Animals were divided in 2 experimental groups: 1) untreated animals acting as control and 2) treated animals in which the toxin was injected in the left muscle, the latter being itself divided into 3 subgroups according to their locomotor recovery with the help of a test based on footprint measurements of walking rats: i) no recovery (B0), ii) 50% recovery (B50) and iii) full recovery (B100). …”
  19. 419
  20. 420